Klinisch bioloog Walter Verstrepen SRL
Klinisch bioloog Walter Verstrepen reported total assets of €2.47m at the end of the 2025 financial year (annual accounts filed with the NBB on 12 Aug 2026).
By total assets for 2025, Klinisch bioloog Walter Verstrepen ranks among the 500 largest of the 15,444 companies in its sector (NACE 8622) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Klinisch bioloog Walter Verstrepen shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +47 % Total assets +3 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Klinisch bioloog Walter Verstrepen's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 12 Aug 2026
- Year ended 31 Dec 2024filed on 06 Aug 2025
- Year ended 31 Dec 2023filed on 29 Aug 2024
- Year ended 31 Dec 2022filed on 29 Aug 2023
- Year ended 31 Dec 2021filed on 19 Aug 2022
Klinisch bioloog Walter Verstrepen's financial analysis
- Solvency97.5%sector median: 72.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Klinisch bioloog Walter Verstrepen
1 active director(s) in the register.
Klinisch bioloog Walter Verstrepen's shareholders and holdings →Klinisch bioloog Walter Verstrepen's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0899.689.648
- VAT number
- BE0899689648
- Peppol
- Registered · 0208:0899689648 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 05 Aug 2008
- Registered office
- 2550 Kontich
- Latest accounts
- 2025 · filed on 12 Aug 2026
- Activity
- Medical specialists activities (NACE 86220)
Klinisch bioloog Walter Verstrepen (SRL) has been based in Kontich since 2008, active in: medical specialists activities. For 2025, it reports a net profit of 215,204 € and equity of €2.41m; its revenue is not published. Its solvency stands at 97.5%, above the median of its sector (72.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Klinisch bioloog Walter Verstrepen
Companies in the same business, of comparable size and area, outside its group.
- DR.Govaere Fabienne Medical specialists activities Berlare · balance sheet €2.39m
- Dr. De Naeyer Geert Medical specialists activities Zottegem · balance sheet €2.29m
- Dr. Abdullah Kaya Medical specialists activities Hasselt · balance sheet €2.26m
- DR.Durnez Pieterjan Medical specialists activities Lichtervelde · balance sheet €2.86m
- Vunjo Medical specialists activities Kampenhout · balance sheet €2.09m
- Medivive Medical specialists activities Roeselare · balance sheet €2.08m
- Dr. KOEN VAN EYGEN Medical specialists activities Kortrijk · balance sheet €1.81m
- Derveaux Oogheelkunde Medical specialists activities Destelbergen · balance sheet €1.75m
Frequently asked questions about Klinisch bioloog Walter Verstrepen
What is the revenue of Klinisch bioloog Walter Verstrepen?
Klinisch bioloog Walter Verstrepen files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Klinisch bioloog Walter Verstrepen?
In Belgium, the VAT number is the company number prefixed with BE: BE0899689648 for Klinisch bioloog Walter Verstrepen, if the company is VAT-registered. Its company number (CBE) is 0899.689.648.
Where is the registered office of Klinisch bioloog Walter Verstrepen?
According to the CBE register, the registered office of Klinisch bioloog Walter Verstrepen is in 2550 Kontich.
What is the equity of Klinisch bioloog Walter Verstrepen?
At the close of the 2025 financial year, the equity of Klinisch bioloog Walter Verstrepen amounts to 2,411,401 €, a solvency of 97.5% of total assets.
Who manages Klinisch bioloog Walter Verstrepen?
The register lists 1 active mandates at Klinisch bioloog Walter Verstrepen. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Klinisch bioloog Walter Verstrepen within its sector?
By total assets for 2025, Klinisch bioloog Walter Verstrepen ranks among the 500 largest of the 15,444 companies in its sector (NACE 8622) in Belgium that filed accounts for that financial year.
The full file of Klinisch bioloog Walter Verstrepen
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →